Aspiro Pharma Limited
Aspiro Pharma Limited appears in FDA public data with 1 recall, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-0036-2026, Class II) was initiated on October 1, 2025.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0036-2026 | Class II | Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscul | October 1, 2025 |